abstract |
The present invention provides isolated peptides or fragments derived from SEQ ID NO: 45 that bind HLA antigens and induce cytotoxic T lymphocytes (CTL). Such peptides may include sequences in which one, two, or several amino acids are substituted, deleted, or added to the amino acid sequences described above. The present invention also provides pharmaceutical compositions comprising these peptides. The peptides of the present invention can be used in the diagnosis or treatment of cancer. |